Relmada Therapeutics (RLMD) Enterprise Value Growth (1y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Relmada Therapeutics | 595.35 Mn | 595.35 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -764.58% |
| Dec 31, 2025 | -107.10% |
| Sep 30, 2025 | 74.34% |
| Jun 30, 2025 | 70.73% |
| Mar 31, 2025 | 67.64% |
| Dec 31, 2024 | 53.38% |
| Sep 30, 2024 | 49.07% |
| Jun 30, 2024 | 40.57% |
| Mar 31, 2024 | 36.87% |
| Dec 31, 2023 | 35.06% |
| Sep 30, 2023 | 42.29% |
| Jun 30, 2023 | 44.08% |
| Mar 31, 2023 | 39.98% |
| Dec 31, 2022 | 30.01% |
| Sep 30, 2022 | -109.06% |
| Jun 30, 2022 | -94.33% |
| Mar 31, 2022 | -114.84% |
| Dec 31, 2021 | -80.98% |
| Sep 30, 2021 | 28.47% |
| Jun 30, 2021 | 18.66% |
| Mar 31, 2021 | 10.63% |
| Dec 31, 2020 | -0.56% |
| Sep 30, 2020 | -1,468.67% |
| Jun 30, 2020 | -1,354.86% |
| Mar 31, 2020 | -5,495.19% |
| Dec 31, 2019 | -4,698.32% |
| Sep 30, 2019 | -784.50% |
| Jun 30, 2019 | -311.65% |
| Mar 31, 2019 | 51.76% |
| Dec 31, 2018 | 59.14% |
| Sep 30, 2018 | 81.05% |
| Jun 30, 2018 | -30.89% |
| Mar 31, 2018 | -54.45% |
| Dec 31, 2017 | -25.99% |
| Sep 30, 2017 | 24.71% |
| Jun 30, 2017 | 79.88% |
| Mar 31, 2017 | 75.71% |
| Dec 31, 2016 | 68.84% |
| Sep 30, 2016 | 67.54% |
| Jun 30, 2016 | 62.17% |
| Mar 31, 2016 | 57.90% |
| Dec 31, 2015 | 51.85% |
| Sep 30, 2015 | 30.03% |
| Jun 30, 2015 | 12.10% |
| Mar 31, 2015 | -996.18% |
| Nov 30, 2013 | 40.97% |
| Aug 31, 2013 | -70.86% |